Swiss Life Asset Management Ltd Has $2.70 Million Stake in Healthpeak Properties, Inc. $DOC

Swiss Life Asset Management Ltd increased its holdings in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 41.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 167,828 shares of the real estate investment trust’s stock after purchasing an additional 49,025 shares during the quarter. Swiss Life Asset Management Ltd’s holdings in Healthpeak Properties were worth $2,699,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. State Street Corp raised its position in Healthpeak Properties by 1.8% during the third quarter. State Street Corp now owns 49,498,109 shares of the real estate investment trust’s stock worth $947,889,000 after acquiring an additional 895,460 shares in the last quarter. JPMorgan Chase & Co. raised its position in shares of Healthpeak Properties by 41.0% in the third quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust’s stock valued at $540,730,000 after purchasing an additional 8,212,504 shares during the period. Cullen Capital Management LLC raised its position in shares of Healthpeak Properties by 6.7% in the third quarter. Cullen Capital Management LLC now owns 10,232,875 shares of the real estate investment trust’s stock valued at $195,960,000 after purchasing an additional 641,771 shares during the period. Dimensional Fund Advisors LP raised its position in shares of Healthpeak Properties by 4.1% in the third quarter. Dimensional Fund Advisors LP now owns 10,228,560 shares of the real estate investment trust’s stock valued at $195,873,000 after purchasing an additional 400,900 shares during the period. Finally, Bank of America Corp DE raised its position in shares of Healthpeak Properties by 28.5% in the third quarter. Bank of America Corp DE now owns 9,936,934 shares of the real estate investment trust’s stock valued at $190,292,000 after purchasing an additional 2,206,222 shares during the period. 93.57% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Weiss Ratings raised shares of Healthpeak Properties from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Morgan Stanley lowered their price target on shares of Healthpeak Properties from $21.00 to $18.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 28th. Wells Fargo & Company reaffirmed a “positive” rating on shares of Healthpeak Properties in a research report on Tuesday, February 3rd. Royal Bank Of Canada raised their price target on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research report on Thursday. Finally, Wall Street Zen raised shares of Healthpeak Properties from a “sell” rating to a “hold” rating in a research report on Sunday, May 10th. Five analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Healthpeak Properties presently has an average rating of “Hold” and an average price target of $18.92.

Healthpeak Properties Price Performance

NYSE:DOC opened at $19.53 on Friday. Healthpeak Properties, Inc. has a 52 week low of $15.70 and a 52 week high of $19.91. The firm has a market cap of $13.46 billion, a price-to-earnings ratio of 61.02, a P/E/G ratio of 2.70 and a beta of 1.00. The firm’s 50-day simple moving average is $17.23 and its 200 day simple moving average is $17.19. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The business had revenue of $752.95 million for the quarter, compared to analyst estimates of $694.59 million. During the same period last year, the firm earned $0.46 earnings per share. Healthpeak Properties’s revenue for the quarter was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, sell-side analysts predict that Healthpeak Properties, Inc. will post 1.74 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently disclosed a monthly dividend, which will be paid on Friday, June 26th. Shareholders of record on Monday, June 15th will be paid a dividend of $0.1017 per share. This represents a c) dividend on an annualized basis and a yield of 6.2%. The ex-dividend date is Monday, June 15th. Healthpeak Properties’s dividend payout ratio is presently 381.25%.

Insider Transactions at Healthpeak Properties

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of the stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total transaction of $213,736.05. Following the sale, the insider directly owned 7,636 shares in the company, valued at $148,520.20. This represents a 59.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.23% of the stock is owned by insiders.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.